Individuals Coming Off Weight-Loss Injections Put On Weight Four Times Faster Compared to People Using Diet and Exercise

Fresh analysis indicates that individuals who stop using blockbuster weight-loss injections like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.

Published data in a major medical journal points out that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.

"Users buying such drugs must be informed of the potential of quick weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.

Such speed of regain suggests a reversion to starting weight in about one and a half years.

Analyzing Approaches

The study, which looked at 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.

Scientists point out that individuals who shed pounds through dieting generally experience a less rapid weight regain—perhaps 100 grams monthly—after stopping.

The Reason for the Fast Rebound

Doctors propose the mode of action of the drugs explains the accelerated regain.

The injections copy a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Sustained high doses of GLP-1 levels far above than normal may cause the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this GLP-1 'fix' means appetite is uncontrolled, making binge eating a significant risk."

A Lifelong Disease?

The NHS suggest the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts contend that, due to the significant potential of relapse, the treatment might need to be long-term.

This view is echoed by pharmaceutical companies, who state that the results "emphasize the chronic character of excess weight," akin to managing conditions like diabetes.

User Experiences

Users who have stopped the medication report a intense resurgence of cravings.

"It felt as if a trigger flipping and you're instantly starving," said one woman.

This difficulty is compounded if patients have not established sustainable dietary or behavioural modifications during therapy.

Growing Adoption

Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.

• Adoption is more common among women compared to men.
• The 40s and 50s demographic shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than public health services.

Ultimately, researchers caution that while these medications are effective tools for shedding pounds, they are not a permanent fix and long-term success relies on combined behavioural management.